CHMP2B and frontotemporal dementia: In a recent MRI study of familiar frontotemporal dementia (FTD-3) prior to symptom onset, the authors found a significant decrease of CBF in temporal, occipital, and parietal regions of familial carriers of the CHMP2B mutation, compared to family members not carrying the mutation.